FDA-approved oral AML therapy could let older patients avoid monthly infusion visits
byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a
Updated on: July 02,2026
FDA-approved oral AML therapy could let older patients avoid monthly infusion visits
byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a
Updated on:July 02,2026
